Literature DB >> 27013132

Quantum dot nanoparticle for optimization of breast cancer diagnostics and therapy in a clinical setting.

Dina Radenkovic1, Hisataka Kobayashi2, Ernö Remsey-Semmelweis3, Alexander M Seifalian4.   

Abstract

Breast cancer is the most common cancer in the world. Sentinel lymph node (SLN) biopsy is used for staging of axillary lymph nodes. Organic dyes and radiocolloid are currently used for SLN mapping, but expose patients to ionizing radiation, are unstable during surgery and cause local tissue damage. Quantum dots (QD) could be used for SLN mapping without the need for biopsy. Surgical resection of the primary tumor is the optimal treatment for early-diagnosed breast cancer, but due to difficulties in defining tumor margins, cancer cells often remain leading to reoccurrences. Functionalized QD could be used for image-guided tumor resection to allow visualization of cancer cells. Near Infrared QD are photostable and have improved deep tissue penetration. Slow elimination of QD raises concerns of potential accumulation. Nevertheless, promising findings with cadmium-free QD in recent in vivo studies and first in-human trial suggest huge potential for cancer diagnostic and therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer imaging; Image-guided surgery; Nanoparticles; Nanotechnology; Quantum dots

Mesh:

Year:  2016        PMID: 27013132     DOI: 10.1016/j.nano.2016.02.014

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

Review 1.  Advances in fluorescent-image guided surgery.

Authors:  Mark J Landau; Daniel J Gould; Ketan M Patel
Journal:  Ann Transl Med       Date:  2016-10

Review 2.  Quantum Dot-Based Simultaneous Multicolor Imaging.

Authors:  Wenxia Wang; Zhen Liu; Xiaoli Lan
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

Review 3.  Nanoparticle-mediated targeted drug delivery for breast cancer treatment.

Authors:  Piumi Y Liyanage; Sajini D Hettiarachchi; Yiqun Zhou; Allal Ouhtit; Elif S Seven; Cagri Y Oztan; Emrah Celik; Roger M Leblanc
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

Review 4.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.